Viewing Study NCT02426268


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2026-01-04 @ 8:46 AM
Study NCT ID: NCT02426268
Status: COMPLETED
Last Update Posted: 2020-11-03
First Post: 2015-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: FORE-SIGHT Tissue Oximeter During Cardiac Surgery
Sponsor: University of California, Los Angeles
Organization:

Study Overview

Official Title: CAS Medical Systems FORE-SIGHT Elite Tissue Oximeter During Cardiac Surgery
Status: COMPLETED
Status Verified Date: 2020-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FORE-SIGHT
Brief Summary: The purpose of this study is to measure cerebral and lower extremity oximetry on patients during cardiac surgery.
Detailed Description: The purpose of this research study is to collect data from a tissue oximeter device that measures brain oxygen saturation simultaneous with data from the same device that monitors skeletal muscle during cardiac surgery. This monitoring will allow for continuous, non-invasive, and earlier assessment of perfusion abnormalities/hypoperfusion.

Two sensors from the FORE-SIGHT Elite monitor will be placed on the forehead above the eyebrows and two additional sensors will be placed on the leg muscles. Data from the FORE-SIGHT Elite monitor will be recorded in addition to clinical and demographic data, which is standard of care during the procedure, for research purposes to look at factors associated with desaturations.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: